Hypersensitivity, Immediate  >>  cyclosporine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT00232076: Verification Study of Ciclosporin for Atopic Dermatitis

Completed
3
Japan
ciclosporin
Novartis Pharmaceuticals
Severe Atopic Dermatitis
03/05
 
NCT00232063: Long-term Study of Ciclosporin for Atopic Dermatitis

Completed
3
Japan
ciclosporin
Novartis Pharmaceuticals
Severe Atopic Dermatitis
11/05
 
NCT00884585: Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis

Completed
3
176
US, Canada, Europe, RoW
Cyclosporine Vehicle, Cyclosporine 0.010%
Allergan
Atopic Conjunctivitis
10/10
07/11
METHODA, NCT00809172: Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients

Completed
3
100
Europe
Ciclosporin, Methotrexate
Hospices Civils de Lyon
Atopic Dermatitis
10/11
04/12

Download Options